Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2026 ,inter alia, to consider and approve AGM

SHUKRA PHARMACEUT‘ICALS LTD. August 17,2026 The Listing Compliance Department The Listing Department BSE Limited National Stock Exchange of India P. J. Towers, Dalal Street Limited Mumbai - 400001 Exchange Plaza, C-1, Block G Scrip Code: 524632 Bandra Kurla Complex, Bandra (East) Mumbai — 400051 Symbol: SHUKRAPHAR Dear Sir/Madam, B: IN' 10N ARD M ING P! ANT ATI EBI G BLI D DI. E REQUIR) RE! 201 Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, August 22, 2026 at the Registered Office of the Company inter alia to consider and approve the following: - 1. To consider and approve the change of Name of the Company subject to approval of shareholders; 2. To consider and approve the change in object clause of the Company and subsequent alteration to the Memorandum of Association of the Company, subject to approval of Shareholders; 3. Toapprove the Draft Notice of the Postal Ballot for seeking consent of the members of the Company for above mentioned agenda. The notice of the said postal ballot shall be submitted to the Stock Exchanges in due course in compliance with the provisions of the SEBI Listing Regulations. 4. To approve appointment of Mrs. Rupal Patel, Practicing Company Secretary as Scrutinizer for postal ballot. 5. To consider and approve draft of Director's Report and Secretarial Audit Report for the year ended March 31, 2026; 6. To fix day, date, time and venue for Annual General meeting; 7. To decide on the dates for closure of the Register of Members and Share Transfer Register for the purpose of Annual Book Closure; 8. To consider and approve draft of notice for Annual General Meeting; 9. To appoint Scrutinizer for the process of Remote E-voting as well as voting at the AGM; CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com PHARMACEUTICALS 10. Any other business with the permission of Chairman. Further, in terms of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the “Trading Window” for dealing in securities of the Company shall remain closed from 17t August, 2026 to 24t August, 2026 (both daysinclusive) i.e. till 48 hours after the public announcement of outcome of Board meeting scheduled to be held on August 22, 2026, for the designated employees of the Company. You are requested to take the above information on records and disseminate the same. Thanking you, Yours faithfully, Company Secretary and pliance officer ACS: A80894 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com